scholarly journals Initial Vancomycin Dosing Recommendations for Critically Ill Patients Undergoing Continuous Venovenous Hemodialysis

2010 ◽  
Vol 63 (3) ◽  
Author(s):  
Sandra A N Walker ◽  
Lyndsay M Van de Vijsel ◽  
Scott E Walker ◽  
Sharon Yamashita ◽  
Andrew Simor ◽  
...  
Keyword(s):  
Critically Ill ◽  
Critically Ill Patients ◽  
Continuous Venovenous Hemodialysis

Pharmacokinetics of Micafungin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis With High Cutoff Membranes

2019 ◽  
Vol 41 (3) ◽  
pp. 376-382 ◽  
Author(s):  
Teresa Tenorio-Cañamás ◽  
Santiago Grau ◽  
Sonia Luque ◽  
Jesús Fortún ◽  
Fernando Liaño ◽  
...  
Keyword(s):  
Critically Ill ◽  
Critically Ill Patients ◽  
Continuous Venovenous Hemodialysis

Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis

2011 ◽  
Vol 39 (1) ◽  
pp. 19-25 ◽  
Author(s):  
A. Mary Vilay ◽  
Maricor Grio ◽  
Daryl D. DePestel ◽  
Kevin M. Sowinski ◽  
Lihong Gao ◽  
...  
Keyword(s):  
Critically Ill ◽  
Critically Ill Patients ◽  
Continuous Venovenous Hemodialysis

scholarly journals Cerebral Gaseous Microemboli are Detectable During Continuous Venovenous Hemodialysis in Critically Ill Patients

2017 ◽  
Vol 29 (3) ◽  
pp. 236-242 ◽  
Author(s):  
Gabor Erdoes ◽  
Clemens Kietaibl ◽  
Stefan Boehme ◽  
Roman Ullrich ◽  
Klaus Markstaller ◽  
...  
Keyword(s):  
Critically Ill ◽  
Critically Ill Patients ◽  
Continuous Venovenous Hemodialysis

Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis

2015 ◽  
Vol 66 (1) ◽  
pp. 173-175 ◽  
Author(s):  
Matthew S. Shotwell ◽  
Phillip N. Madonia ◽  
Michael J. Connor ◽  
Milen Amde ◽  
Charbel Salem ◽  
...  
Keyword(s):  
Critically Ill ◽  
Critically Ill Patients ◽  
Continuous Venovenous Hemodialysis

scholarly journals Pharmacokinetics of Caspofungin in Critically Ill Patients on Continuous Renal Replacement Therapy

2013 ◽  
Vol 57 (8) ◽  
pp. 4053-4057 ◽  
Author(s):  
Stefan Weiler ◽  
Christoph Seger ◽  
Hartwig Pfisterer ◽  
Eva Stienecke ◽  
Florian Stippler ◽  
...  
Keyword(s):  
Renal Replacement Therapy ◽  
Continuous Renal Replacement Therapy ◽  
Healthy Volunteers ◽  
Replacement Therapy ◽  
Critically Ill ◽  
Critically Ill Patients ◽  
Control Group ◽  
Continuous Venovenous Hemofiltration ◽  
Standard Dosage ◽  
Continuous Venovenous Hemodialysis

ABSTRACTCaspofungin pharmacokinetics was assessed in 27 critically ill patients, including 7 on continuous venovenous hemofiltration (CVVH), 8 on continuous venovenous hemodialysis (CVVHD), and 13 not requiring continuous renal replacement therapy (CRRT). Caspofungin exposure during CRRT was very similar to that of the control group and comparable to that in healthy volunteers. Caspofungin clearance by CRRT was very low. Therefore, the standard dosage of caspofungin is probably adequate for critically ill patients undergoing CVVH or CVVHD.

Renal replacement therapy in critical care: implementation of a unit-based continuous venovenous hemodialysis program

1998 ◽  
Vol 18 (1) ◽  
pp. 40-51 ◽  
Author(s):  
KK Giuliano ◽  
EE Pysznik
Keyword(s):  
Renal Failure ◽  
Critical Care ◽  
Renal Replacement Therapy ◽  
Replacement Therapy ◽  
Critically Ill ◽  
Critically Ill Patients ◽  
Intermittent Hemodialysis ◽  
Staff Support ◽  
Successful Program ◽  
Continuous Venovenous Hemodialysis

Implementing a program as complex as continuous venovenous hemodialysis without the involvement of nephrology nurses is a challenge. However, with proper planning, appropriate staff support, and the ability to make changes as implementation proceeds, a successful program can be developed. Our reward is that we are now able to offer a therapy that is important and potentially lifesaving to those critically ill patients with renal failure who are unable to tolerate intermittent hemodialysis.

Sign in / Sign up

Export Citation Format

Share Document